Company · CIK 0001600132 · SIC 2834 — Pharmaceutical Preparations
Bellerophon Therapeutics, Inc. · BLPH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2019 PForm 4 → | Jan 25, 4:22 pm EST | Theodore T WangDirector, 10% Owner | 450,000 | $0.70 | $315,000 | 463,699 | +3,285% | plan? |
| Jan 25, 2019 PForm 4 → | Jan 25, 4:21 pm EST | Jonathan M PeacockDirector | 714,286 | $0.70 | $500,000 | 1,855,920 | +62.6% | plan? |
| Jan 25, 2019 PForm 4 → | Jan 25, 4:12 pm EST | Naseem AminDirector | 571,429 | $0.70 | $400,000 | 1,818,867 | +45.8% | plan? |
| Jan 23, 2019 AForm 4 → | Jan 25, 4:21 pm EST | Jonathan M PeacockDirector | 227,273 | — | — | 1,141,634 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:19 am EDT | Amy EdmondsVP Clinical Operations & Admin | 82,243 | — | — | 176,043 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:18 am EDT | Martin DekkerVP of Engineering & Manuf | 82,243 | — | — | 151,753 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:18 am EDT | Parag Suresh ShahVP Proj Mgmt & Distribution | 78,505 | — | — | 131,599 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:17 am EDT | Peter FernandesChief Regulatory & Safety Offr | 119,626 | — | — | 222,302 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:16 am EDT | Fabian TenenbaumChief Executive Officer | 224,299 | — | — | 479,282 | — | plan? |
| Sep 25, 2018 AForm 4 → | Sep 27, 8:15 am EDT | Assaf KornerCFO | 99,065 | — | — | 99,065 | — | plan? |
| Sep 13, 2018 PForm 4 → | Sep 17, 4:46 pm EDT | VENROCK ASSOCIATES IV L P +410% Owner | 210,000 | $1.20 | $252,354 | 7,386,163 | +2.93% | plan? |
| Sep 13, 2018 PForm 4 → | Sep 17, 4:42 pm EDT | VENROCK ASSOCIATES IV L P +910% Owner | 210,000 | $1.20 | $252,354 | 7,386,163 | +2.93% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 12, 9:00 pm EDT | VENROCK ASSOCIATES IV L P +410% Owner | 475,000 | $1.18 | $558,393 | 7,176,163 | +7.09% | plan? |
| Sep 10, 2018 PForm 4 → | Sep 12, 9:00 pm EDT | VENROCK ASSOCIATES IV L P +910% Owner | 475,000 | $1.18 | $558,393 | 7,176,163 | +7.09% | plan? |
| Sep 5, 2018 PForm 4 → | Sep 7, 5:45 pm EDT | VENROCK ASSOCIATES IV L P +910% Owner | 160,000 | $0.8635 | $138,162 | 6,701,163 | +2.45% | plan? |
| Sep 5, 2018 PForm 4 → | Sep 7, 5:42 pm EDT | VENROCK ASSOCIATES IV L P +410% Owner | 160,000 | $0.8635 | $138,162 | 6,701,163 | +2.45% | plan? |
| Aug 14, 2018 PForm 4 → | Aug 16, 7:33 pm EDT | VENROCK ASSOCIATES IV L P +110% Owner | 529,370 | $0.6477 | $342,879 | 6,541,163 | +8.81% | plan? |
| Aug 14, 2018 PForm 4 → | Aug 16, 7:31 pm EDT | VENROCK ASSOCIATES IV L P +910% Owner | 529,370 | $0.6477 | $342,879 | 6,541,163 | +8.81% | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:33 pm EDT | Andre V. MouraDirector | 15,411 | — | — | 68,736 | — | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:33 pm EDT | Daniel TasseDirector | 11,987 | — | — | 182,604 | — | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:32 pm EDT | Jens LuehringDirector | 14,555 | — | — | 95,213 | — | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:32 pm EDT | Theodore T WangDirector, 10% Owner | 13,699 | — | — | 13,699 | — | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:31 pm EDT | Naseem AminDirector | 17,124 | — | — | 1,247,438 | — | plan? |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:31 pm EDT | Matthew BennettDirector | 11,987 | — | — | 30,552 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:42 pm EDT | Deborah QuinnChief Medical Officer | 10,541 | $2.37 | $24,982 | 94,070 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:41 pm EDT | Parag Suresh ShahVP Proj Mgmt & Distribution | 7,144 | $2.37 | $16,931 | 53,094 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:40 pm EDT | Amy EdmondsVP Clinical Operations & Admin | 7,499 | $2.37 | $17,773 | 93,800 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:39 pm EDT | Fabian TenenbaumChief Executive Officer | 63,486 | $2.37 | $150,462 | 254,983 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:37 pm EDT | Peter FernandesChief Regulatory & Safety Offr | 11,304 | $2.37 | $26,790 | 102,676 | — | plan? |
| Jun 12, 2018 FForm 4 → | Jun 14, 4:35 pm EDT | Martin DekkerVP of Engineering & Manuf | 7,473 | $2.37 | $17,711 | 69,510 | — | plan? |
| Apr 2, 2018 AForm 4 → | Apr 3, 5:40 pm EDT | Jonathan M PeacockDirector | 99,010 | — | — | 914,361 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:01 pm EST | Martin DekkerVP of Engineering & Manuf | 21,675 | — | — | 76,983 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:00 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 20,690 | — | — | 60,238 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:56 pm EST | Peter FernandesChief Regulatory & Safety Offr | 31,527 | — | — | 113,980 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:55 pm EST | Fabian TenenbaumChief Executive Officer | 55,419 | — | — | 318,469 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:42 pm EST | Deborah QuinnChief Medical Officer | 29,557 | — | — | 104,611 | — | plan? |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:41 pm EST | Amy EdmondsVP Clinical Operations & Admin | 21,675 | — | — | 101,299 | — | plan? |
| Jan 4, 2018 FForm 4 → | Jan 8, 5:26 pm EST | Peter FernandesChief Regulatory & Safety Offr | 35,321 | $2.49 | $87,949 | 82,453 | — | plan? |
| Jan 4, 2018 FForm 4 → | Jan 8, 4:52 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 23,180 | $2.49 | $57,718 | 39,548 | — | plan? |
| Jan 4, 2018 FForm 4 → | Jan 8, 4:49 pm EST | Martin DekkerVP of Engineering & Manuf | 24,284 | $2.49 | $60,467 | 55,308 | — | plan? |
| Jan 4, 2018 FForm 4 → | Jan 8, 4:46 pm EST | Deborah QuinnChief Medical Officer | 33,114 | $2.49 | $82,454 | 75,054 | — | plan? |
| Dec 13, 2017 MForm 4 → | Dec 13, 4:36 pm EST | Megan SchoepsPrincipal Financial Officer | 1,000 | $0.49 | $490 | 19,248 | — | plan? |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:07 pm EDT | Naseem AminDirector | 456,432 | — | — | 1,230,314 | — | plan? |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 80,658 | — | plan? |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jonathan M PeacockDirector | 248,962 | — | — | 815,351 | — | plan? |
| Jun 28, 2017 AForm 4 → | Jul 3, 6:50 am EDT | Adam WeinsteinDirector, 10% Owner | 25,363 | — | — | 42,130 | — | plan? late |
| Jun 28, 2017 AForm 4 → | Jul 3, 6:50 am EDT | Naseem AminDirector | 36,232 | — | — | 773,882 | — | plan? late |
| Jun 28, 2017 AForm 4 → | Jun 30, 6:44 pm EDT | Jonathan M PeacockDirector | 57,972 | — | — | 566,389 | — | plan? |
| Jun 28, 2017 AForm 4 → | Jun 30, 6:44 pm EDT | Jens LuehringDirector, 10% Owner | 30,798 | — | — | 70,658 | — | plan? |
| Jun 28, 2017 AForm 4 → | Jun 30, 6:43 pm EDT | Andre V. MouraDirector | 32,609 | — | — | 53,325 | — | plan? |
| Jun 28, 2017 AForm 4 → | Jun 30, 6:43 pm EDT | Daniel TasseDirector | 25,363 | — | — | 170,617 | — | plan? |
| May 17, 2017 FForm 4 → | May 19, 4:04 pm EDT | Megan SchoepsPrincipal Financial Officer | 10,459 | $1.40 | $14,683 | 18,248 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:32 pm EDT | Megan SchoepsPrincipal Financial Officer | 24,039 | — | — | 28,707 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:29 pm EDT | Parag Suresh ShahVP Proj Mgmt & Distribution | 53,847 | — | — | 62,728 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:27 pm EDT | Deborah QuinnChief Medical Officer | 76,924 | — | — | 108,168 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:26 pm EDT | Peter FernandesChief Regulatory & Safety Offr | 82,052 | — | — | 117,774 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:25 pm EDT | Amy EdmondsVP Clinical Operations & Admin | 56,411 | — | — | 79,624 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:24 pm EDT | Martin DekkerVP of Engineering & Manuf | 56,411 | — | — | 79,592 | — | plan? |
| Mar 16, 2017 AForm 4 → | Mar 20, 4:23 pm EDT | Fabian TenenbaumChief Executive Officer | 120,193 | — | — | 263,050 | — | plan? |
| Dec 9, 2016 PForm 4 → | Dec 12, 10:10 am EST | Jens LuehringDirector, 10% Owner | 20,000 | $0.56 | $11,200 | 39,860 | +101% | plan? |
| Nov 29, 2016 PForm 5 → | Jan 2, 2018, 1:39 pm EST | Linde North America, Inc.10% Owner | 3,641,992 | — | — | 5,271,796 | — | plan? |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:57 am EST | Naseem AminDirector | 714,285 | — | — | 737,650 | — | plan? |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:40 am EST | Fabian TenenbaumChief Executive Officer | 142,857 | — | — | 142,857 | — | plan? |
| Nov 29, 2016 PForm 4 → | Nov 30, 3:31 pm EST | Jonathan M PeacockDirector | 285,715 | — | — | 508,417 | — | plan? |
| Sep 12, 2016 FForm 4 → | Sep 13, 8:21 pm EDT | Deborah QuinnChief Medical Officer | 18,548 | $1.38 | $25,596 | 31,244 | — | plan? |
| Sep 12, 2016 FForm 4 → | Sep 13, 8:18 pm EDT | Parag Suresh ShahVP Proj Mgmt & Distribution | 4,673 | $1.38 | $6,449 | 8,881 | — | plan? |
| Sep 12, 2016 FForm 4 → | Sep 13, 8:16 pm EDT | Martin DekkerVP of Device Engineering | 13,333 | $1.38 | $18,400 | 23,181 | — | plan? |
| Sep 12, 2016 FForm 4 → | Sep 13, 8:14 pm EDT | Amy EdmondsVP Clinical Operations & Admin | 13,301 | $1.38 | $18,355 | 23,213 | — | plan? |
| Sep 12, 2016 FForm 4 → | Sep 13, 8:11 pm EDT | Peter FernandesChief Regulatory Officer | 19,785 | $1.38 | $27,303 | 35,722 | — | plan? |
| May 17, 2016 PForm 4 → | May 18, 1:46 pm EDT | Jonathan M PeacockPresident and CEO, Director | 5,000 | $1.37 | $6,842 | 222,702 | +2.30% | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:59 pm EDT | Andre V. MouraDirector | 20,716 | — | — | 20,716 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:57 pm EDT | Adam WeinsteinDirector, 10% Owner | 16,767 | — | — | 16,767 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:56 pm EDT | Naseem AminDirector | 23,365 | — | — | 23,365 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:44 pm EDT | Mary Ann CloydDirector | 21,858 | — | — | 21,858 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:39 pm EDT | Jens LuehringDirector, 10% Owner | 19,860 | — | — | 19,860 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:34 pm EDT | Matthew S. HoltDirector, 10% Owner | 18,232 | — | — | 18,232 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:30 pm EDT | Scott P BruderDirector | 18,692 | — | — | 18,692 | — | plan? |
| Apr 28, 2016 AForm 4 → | Apr 29, 3:29 pm EDT | Daniel TasseDirector | 16,356 | — | — | 145,254 | — | plan? |
| Jan 25, 2016 AForm 4 → | Jan 27, 4:18 pm EST | Jonathan M PeacockPresident and CEO, Director | 165,975 | — | — | 217,702 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:40 pm EST | Peter FernandesChief Regulatory Officer | 53,112 | — | — | 55,507 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:39 pm EST | Deborah QuinnChief Medical Officer | 49,792 | — | — | 49,792 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:38 pm EST | Amy EdmondsVP Clinical Operations & Admin | 36,514 | — | — | 36,514 | — | plan? |
| Jan 19, 2016 AForm 4 → | Jan 21, 4:38 pm EST | Martin DekkerVP of Device Engineering | 36,514 | — | — | 36,514 | — | plan? |
| Dec 15, 2015 PForm 4 → | Dec 17, 5:01 pm EST | Jonathan M PeacockPresident and CEO, Director | 20,300 | $2.75 | $55,736 | 51,727 | +64.6% | plan? |
| Dec 1, 2015 AForm 4 → | Dec 3, 5:17 pm EST | David AbramsTreasurer | 13,116 | — | — | 13,116 | — | plan? |
| Aug 19, 2015 PForm 4 → | Aug 20, 5:34 pm EDT | Jonathan M PeacockPresident and CEO, Director | 5,000 | $5.48 | $27,377 | 31,427 | +18.9% | plan? |
| May 20, 2015 PForm 4 → | May 22, 7:32 am EDT | Martin MeglassonChief Scientific Officer | 712 | $8.40 | $5,981 | 19,098 | +3.87% | plan? |
| May 20, 2015 PForm 4 → | May 22, 7:32 am EDT | Jonathan M PeacockPresident and CEO, Director | 5,560 | $8.69 | $48,323 | 26,427 | +26.6% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:48 pm EST | ARCH VENTURE FUND VI LP +410% Owner | 212,666 | $12.00 | $2,551,992 | 965,660 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:47 pm EST | Robert NelsenDirector, 10% Owner | 212,666 | $12.00 | $2,551,992 | 965,660 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:47 pm EST | New Mountain Investments II, LLC +710% Owner | 1,070,166 | $12.00 | $12,841,992 | 4,859,885 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:47 pm EST | Adam WeinsteinDirector, 10% Owner | 1,070,166 | $12.00 | $12,841,992 | 4,859,885 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:46 pm EST | Matthew S. HoltDirector, 10% Owner | 1,070,166 | $12.00 | $12,841,992 | 4,859,885 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:41 pm EST | Linde North America, Inc.10% Owner | 358,916 | $12.00 | $4,306,992 | 1,629,804 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:41 pm EST | Jens LuehringDirector, 10% Owner | 358,916 | $12.00 | $4,306,992 | 1,629,804 | +28.2% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:41 pm EST | Daniel TasseDirector | 25,000 | $12.00 | $300,000 | 128,898 | +24.1% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:40 pm EST | Reinilde HeyrmanChief Clinical Dev. Officer | 1,500 | $12.00 | $18,000 | 9,483 | +18.8% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:39 pm EST | Martin MeglassonChief Scientific Officer | 12,000 | $12.00 | $144,000 | 18,386 | +188% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:39 pm EST | Manesh NaiduChief Business Officer | 1,500 | $12.00 | $18,000 | 11,319 | +15.3% | plan? |
| Feb 19, 2015 PForm 4 → | Feb 23, 9:39 pm EST | Jonathan M PeacockPresident and CEO, Director | 20,800 | $12.00 | $249,600 | 20,867 | +31,045% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2019 AForm 4 → | Jan 4, 4:30 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 12,500 | — | — | 260,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:30 pm EST | Peter FernandesChief Regulatory & Safety Offr | 12,500 | — | — | 294,790 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:29 pm EST | Fabian TenenbaumChief Executive Officer | 12,500 | — | — | 3,688,697 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:28 pm EST | Amy EdmondsVP Clinical Operations & Admin | 12,500 | — | — | 270,386 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:27 pm EST | Martin DekkerVP of Engineering & Manuf | 12,500 | — | — | 262,983 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:26 pm EST | Assaf KornerCFO | 12,500 | — | — | 250,000 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:25 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 137,500 | — | — | 247,500 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:25 pm EST | Peter FernandesChief Regulatory & Safety Offr | 137,500 | — | — | 282,290 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:24 pm EST | Fabian TenenbaumChief Executive Officer | 1,487,500 | — | — | 3,676,197 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:24 pm EST | Amy EdmondsVP Clinical Operations & Admin | 137,500 | — | — | 257,886 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:23 pm EST | Martin DekkerVP of Engineering & Manuf | 137,500 | — | — | 250,483 | — | |
| Nov 20, 2018 AForm 4 → | Nov 23, 4:23 pm EST | Assaf KornerCFO | 137,500 | — | — | 237,500 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:54 pm EDT | Matthew BennettDirector | 38,216 | $2.27 | $86,750 | 38,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:53 pm EDT | Daniel TasseDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:52 pm EDT | Scott P BruderDirector | 38,216 | $2.27 | $86,750 | 83,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:50 pm EDT | Andre V. MouraDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:49 pm EDT | Mary Ann CloydDirector | 38,216 | $2.27 | $86,750 | 73,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:48 pm EDT | Jens LuehringDirector | 38,216 | $2.27 | $86,750 | 58,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:46 pm EDT | Naseem AminDirector | 38,216 | $2.27 | $86,750 | 83,216 | — | |
| Jun 5, 2018 AForm 4 → | Jun 7, 4:44 pm EDT | Theodore T WangDirector, 10% Owner | 38,216 | $2.27 | $86,750 | 63,216 | — | |
| Jan 17, 2018 AForm 4 → | Jan 17, 4:52 pm EST | Assaf KornerCFO | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:01 pm EST | Martin DekkerVP of Engineering & Manuf | 80,000 | — | — | 80,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 5:00 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 80,000 | — | — | 80,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:56 pm EST | Peter FernandesChief Regulatory & Safety Offr | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:55 pm EST | Fabian TenenbaumChief Executive Officer | 550,000 | — | — | 550,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:42 pm EST | Deborah QuinnChief Medical Officer | 100,000 | — | — | 100,000 | — | |
| Jan 12, 2018 AForm 4 → | Jan 17, 4:41 pm EST | Amy EdmondsVP Clinical Operations & Admin | 80,000 | — | — | 80,000 | — | |
| Dec 13, 2017 MForm 4 → | Dec 13, 4:36 pm EST | Megan SchoepsPrincipal Financial Officer | 1,000 | — | — | 3,000 | — | |
| Dec 12, 2017 AForm 4 → | Dec 14, 4:34 pm EST | Theodore T WangDirector, 10% Owner | 25,000 | — | — | 25,000 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:07 pm EDT | Naseem AminDirector | 456,432 | — | — | 456,432 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 29, 2017 PForm 4 → | Oct 3, 4:06 pm EDT | Jonathan M PeacockDirector | 248,962 | — | — | 248,962 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 5:01 pm EDT | Mary Ann CloydDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 5:00 pm EDT | Naseem AminDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:59 pm EDT | Scott P BruderDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:59 pm EDT | Daniel TasseDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:56 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:54 pm EDT | Jonathan M PeacockDirector | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:53 pm EDT | Adam WeinsteinDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Sep 22, 2017 AForm 4 → | Sep 26, 4:52 pm EDT | Andre V. MouraDirector | 10,000 | — | — | 10,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:28 pm EST | Jonathan M PeacockDirector | 588,373 | — | — | 588,373 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:27 pm EST | Martin DekkerVP of Device Engineering | 25,000 | — | — | 25,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:26 pm EST | Parag Suresh ShahVP Proj Mgmt & Distribution | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:24 pm EST | Deborah QuinnChief Medical Officer | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:23 pm EST | Peter FernandesChief Regulatory Officer | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:22 pm EST | Amy EdmondsVP Clinical Operations & Admin | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 9, 4:21 pm EST | Fabian TenenbaumChief Executive Officer | 1,042,556 | — | — | 1,042,556 | — | |
| Nov 29, 2016 PForm 5 → | Jan 2, 2018, 1:39 pm EST | Linde North America, Inc.10% Owner | 3,641,992 | — | — | 1,721,992 | — | |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:57 am EST | Naseem AminDirector | 714,285 | — | — | 714,285 | — | |
| Nov 29, 2016 PForm 4 → | Dec 1, 10:40 am EST | Fabian TenenbaumChief Executive Officer | 142,857 | — | — | 142,857 | — | |
| Nov 29, 2016 PForm 4 → | Nov 30, 3:31 pm EST | Jonathan M PeacockDirector | 285,715 | — | — | 285,715 | — | |
| Nov 11, 2016 AForm 4 → | Nov 15, 5:19 pm EST | Fabian TenenbaumChief Executive Officer | 466,141 | — | — | 466,141 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:30 pm EDT | Naseem AminDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:27 pm EDT | Scott P BruderDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:24 pm EDT | Adam WeinsteinDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:21 pm EDT | Matthew S. HoltDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:17 pm EDT | Daniel TasseDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:15 pm EDT | Andre V. MouraDirector | 10,000 | — | — | 10,000 | — | |
| Jun 17, 2016 AForm 4 → | Jun 21, 6:10 pm EDT | Jens LuehringDirector, 10% Owner | 10,000 | — | — | 10,000 | — | |
| Feb 29, 2016 AForm 4 → | Mar 1, 4:03 pm EST | Fabian TenenbaumCFO & Chief Business Officer | 130,000 | — | — | 130,000 | — | |
| Feb 11, 2016 AForm 4 → | Feb 16, 5:37 pm EST | Mary Ann CloydDirector | 25,000 | — | — | 25,000 | — | |
| Jul 8, 2015 AForm 4 → | Jul 13, 6:50 am EDT | Amit AgrawalChief Operating Officer | 100,000 | — | — | 100,000 | — | late |
| Jun 29, 2015 AForm 4 → | Jul 1, 4:59 pm EDT | Naseem AminDirector | 25,000 | — | — | 25,000 | — | |
| May 18, 2015 AForm 4 → | May 20, 8:31 pm EDT | Peter FernandesChief Regulatory Officer | 10,000 | — | — | 10,000 | — | |
| May 12, 2015 AForm 4 → | May 14, 7:37 pm EDT | R Scott HuennekensDirector | 25,000 | — | — | 25,000 | — | |
| May 12, 2015 AForm 4 → | May 14, 7:36 pm EDT | Scott P BruderDirector | 25,000 | — | — | 25,000 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:06 pm EDT | David AbramsTreasurer | 2,564 | — | — | 2,564 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:06 pm EDT | Reinilde HeyrmanChief Clinical Dev. Officer | 9,909 | — | — | 9,909 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:05 pm EDT | Martin MeglassonChief Scientific Officer | 8,297 | — | — | 8,297 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:03 pm EDT | Manesh NaiduChief Business Officer | 4,892 | — | — | 4,892 | — | |
| Mar 12, 2015 AForm 4 → | Mar 16, 5:00 pm EDT | Jonathan M PeacockPresident and CEO, Director | 76,000 | — | — | 60,000 | — | |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:29 pm EST | Manesh NaiduChief Business Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:29 pm EST | Martin MeglassonChief Scientific Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:28 pm EST | Reinilde HeyrmanChief Clinical Dev. Officer | 1,995 | — | — | 1,995 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 19, 5:28 pm EST | David AbramsTreasurer | 1,995 | — | — | 1,995 | — | late |